BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND IKBKB, O14920, 3551, ENSG00000104365
8 results:

  • 1. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
    Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
    Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni SC; Sundaram PS; Padma S
    Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic cancer in the United States.
    Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
    JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
    J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
    Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Morita S; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
    BMC Cancer; 2014 Sep; 14():717. PubMed ID: 25256077
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A new 5-grading score in the diagnosis of prostate cancer with real-time elastography.
    Xu G; Feng L; Yao M; Wu J; Guo L; Yao X; Zhao L; Xu H; Wu R
    Int J Clin Exp Pathol; 2014; 7(7):4128-35. PubMed ID: 25120792
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
    Pflueger D; Terry S; Sboner A; Habegger L; Esgueva R; Lin PC; Svensson MA; Kitabayashi N; Moss BJ; MacDonald TY; Cao X; Barrette T; Tewari AK; Chee MS; Chinnaiyan AM; Rickman DS; Demichelis F; Gerstein MB; Rubin MA
    Genome Res; 2011 Jan; 21(1):56-67. PubMed ID: 21036922
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic biomarkers of prostate cancer.
    Häggarth L; Hägglöf C; Jaraj SJ; Wester K; Pontén F; Ostman A; Egevad L
    Scand J Urol Nephrol; 2011 Feb; 45(1):60-7. PubMed ID: 21034352
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.